Autoimmune pleurisy is an inflammatory condition that alters respiratory mechanics due to a failure in the recognition of the defensive system. In a normal state of health, the pulmonary pleura consists of two thin layers that allow the smooth sliding of the lungs during inhalation. However, this balance is broken when immune system diseases, such as systemic lupus erythematosus or rheumatoid arthritis, attack this tissue. This pathology is characterized by severe inflammation of the pleural membrane that lines the lungs and the chest cavity. Therefore, surfaces that should be smooth become rough and generate painful friction with every respiratory movement. Consequently, the result is a clinical picture dominated by sharp pain and restriction of lung expansion.
Moreover, the inflammation of the pleura generates a biological response that alters the production of lubricating fluid in the pleural space. It is important to highlight that the sharp pain manifests with greater intensity when taking deep breaths, coughing, or making sudden movements of the torso. Nevertheless, autoimmune pleurisy differs from infectious causes due to its systemic nature and its tendency towards chronicity. As a result, the visual comparison between a healthy pleura and one affected by inflammation reveals a notable thickening and reddening of the tissue. The pleural membrane loses its original transparency and elasticity due to the deposition of immune complexes and inflammatory cells.
For this reason, diagnosing this condition requires a comprehensive evaluation of symptoms and the detection of specific autoantibodies. In view of this, doctors look for signs of pleural rub through auscultation, a characteristic sound similar to stretching leather. Due to this condition, fluid accumulation can lead to an effusion that worsens the difficulty in breathing. On the other hand, pharmacological management based on corticosteroids and immunomodulatory agents is usually effective in reducing inflammation. Accordingly, the pulmonary pleura gradually recovers its function if the underlying disease is properly controlled to avoid permanent damage.
Finally, the comprehensive management of autoimmune pleurisy seeks to alleviate the patient’s suffering and prevent the formation of scars or pleural adhesions. Although the pain can be limiting, timely treatment prevents complications such as trapped lung or respiratory failure. In summary, continuous monitoring by rheumatologists and pulmonologists is essential to adjust medication dosages. Ultimately, the main goal is to normalize the state of the serous membranes so that breathing becomes a fluid and painless process once again. Lastly, education regarding the triggers of the disease helps to minimize the frequency of inflammatory outbreaks.